2025
|
Invention
|
Inhibitors of kif18a and uses thereof.
Provided are compounds of the Formula (IIIA):
Provided ... |
2024
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof.
Provided are compounds of the Formula (I):
P... |
|
Invention
|
Inhibitors of the rna helicase dhx9 for use in the treatment of dna damage repair deficient, homo... |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof. Provided are compounds of the Formula (I): or p... |
|
Invention
|
Assays for monitoring inhibition of rna helicase dhx9. AluAlu-mediated circular RNA induced by th... |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof. Provided are compounds of the Formula (IVB):
... |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof. Provided are compounds of the Formula (IIB):
... |
2023
|
Invention
|
Inhibitors of kif18a and uses thereof. Provided are compounds of the Formula (I) or pharmaceutica... |
|
Invention
|
Inhibitors of kif18a and uses thereof |
|
Invention
|
Inhibitors of kif18a and uses thereof. Provided are compounds of the Formula (I): or pharmaceutic... |
|
Invention
|
Inhibitors of kif18a and uses thereof. Provided are compounds of the Formula (I), or pharmaceutic... |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof.
Provided are compounds of the Formula (I): or ... |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof |
|
Invention
|
Inhibitors of rna helicase dhx9 and uses thereof. Provided are compounds of the Formula (I); or p... |
2021
|
Invention
|
Mettl3 modulators.
Provided are compounds of Formula (I′) or (I) below, or pharmaceutically acce... |
|
Invention
|
Mettl3 modulators. Provided are compounds of Formula (I') or (I) below, or pharmaceutically accep... |
|
G/S
|
Pharmaceutical preparations for treating cancer Research and development of pharmaceutical prepar... |
2020
|
Invention
|
Mettl3 modulators.
Provided are compounds of Formula (I′) or (II′), or pharmaceutically acceptab... |
|
Invention
|
Mettl3 modulators. Provided are compounds of Formula (I') or (II'), or pharmaceutically acceptabl... |